Description |
1 online resource (viii, 296 pages) |
Series |
Cancer immunotherapy, 2662-8392 ; volume 2 |
|
Cancer immunotherapy, 2662-8392 v. 2
|
Contents |
Part I Role of the Tumor Microenvironment -- An Overview of the Tumor Microenvironment and Response to Immunotherapy in Gastrointestinal Malignancies -- Part II Esophagus -- Approach to Immunotherapy in Oesophageal Cancer -- Perspective on the Immunotherapy of Esophageal Cancer -- Part III Stomach -- Immunotherapy of Gastric Cancer: Focus on Perioperative Strategies -- Stomach: The Standard of Care ± HER2 -- Perspective on the Immunotherapy of Gastric Cancer -- Part IV Colon -- Immunotherapy in dMMR/MSI-H Colon Cancer -- Immunotherapy in the Treatment of Advanced Colorectal Cancer -- Immunotherapy of Rectal Cancer -- Perspective on Immunotherapy of Colon Cancer: Challenges for the Future -- Part V HCC -- Immune Strategies for Gastrointestinal Cancer: HCC -- Immunotherapy in GI Cancers: Hepatocellular Carcinoma: Perspective -- Part VI Biliary Tract -- Immunotherapy of Biliary Tract Cancer -- Perspective on Immunotherapy Use in Biliary Tract Cancer -- Part VII Pancreas -- Immune Landscape of Pancreas Ductal Adenocarcinoma: Current Therapeutic Strategies and Future Perspective -- Perspective on the Immunotherapy of Pancreatic Cancer -- Part VIII Biomarkers for Immunotherapy in Gastrointestinal Cancers -- Biomarkers for Immunotherapy in Gastrointestinal Cancers |
Summary |
This book provides an overview of the available evidence surrounding immunotherapy in gastrointestinal cancers, and discusses its future place in clinical practice. Immunotherapy has celebrated some astonishing therapeutic successes in a variety of cancer types and is becoming increasingly relevant in daily clinical practice. Currently, the predominant class of immunotherapeutic drugs is the so-called checkpoint inhibitors, which disengage the physiological brakes on the immune system, enabling a more effective anti-cancer immune response. Malignancies of the gastrointestinal tract, which account for the majority of cancer cases worldwide, are a major cause of morbidity and mortality, creating an urgent need for more effective therapies. A large number of clinical trials have evaluated the efficacy of cancer immunotherapy in gastrointestinal malignancies and demonstrated its potential in certain subsets of patients. This book will appeal to a wide readership, including oncologists, health care professionals in general and biomedical scientists |
Notes |
Online resource; title from PDF title page (SpringerLink, viewed January 10, 2024) |
Subject |
Gastrointestinal system -- Cancer -- Immunotherapy
|
Form |
Electronic book
|
Author |
Moehler, Markus, editor
|
|
Foerster, Friedrich, editor
|
ISBN |
9783031399442 |
|
3031399447 |
|